Mind Medicine (MindMed) Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
So I promise this session will be quite interesting. This is a panel and it really should be two separate sessions because there's a lot to talk about for these two companies. So this is a panel that is meant to -- I'll call it -- illustrate emerging and I think quite interesting therapeutic candidates to treat mental health disorders.
So these are two companies that are emerging that will have data by the end of this year that will enable a path forward, perhaps even registrational studies. So that's why we're having this panel. They are two companies that I actually cover. Cybin is a company that has a couple of candidates that will read out by the end of this year.
And with us today is Doug Drysdale, the company's CEO; as well as George Tziras, the CEO of a company called Small Pharma. And the reason they're together is because they're merging and expanding their pipeline. And then the other company's called MindMed, and we have the pleasure -- I have the pleasure -- of introducing Dr. Dan Karlin, the company's Chief Medical Officer, and he
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
